Antibody responses to HIV-1 antigens are higher in HIV-1(+) intravenous drug users than in HIV-1(+) homosexuals

被引:3
|
作者
Jiang, JD [1 ]
Bekesi, GJ [1 ]
机构
[1] Mt Sinai Sch Med, Div Med Oncol, New York, NY 10029 USA
关键词
antibody; HIV-1; homosexuals; immunophenotype; IVDU;
D O I
10.1016/S0753-3322(01)00065-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Immune responses to HIV-1 infection of 42 HIV-1-positive asymptomatic intravenous drug users (IVDUs) were compared with those of 135 HIV-1-infected asymptomatic homosexual men in the present study. Twenty-five HIV-1(-) individuals served as normal controls. The comparison included antibody responses to five computer-predicted epitopes of HIV-1 p17, and viral proteins gp120 and p24 as well as p17. Major immunophenotypes were also investigated. Results showed that antibody responses to the five epitopes were significantly higher in the IVDUs. A larger proportion of the IVDUs, with respect to that of homosexuals, showed positive antibody responses to p24 and p17, respectively. However, the antibody response to gp120 was similar between the two cohorts. Immunophenotyping showed that HIV-1(+) homosexuals had higher profiles in most of the major subsets than did the IVDUs, especially in the total count of lymphocytes, absolute numbers of CD3+ cells and CD8+ cells. It appeared that the HIV-1(+) IVDU cohort had higher antibody responses to most of the viral antigens, but had lower levels of lymphocyte subsets in comparison with HIV(+) homosexuals. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:313 / 315
页数:3
相关论文
共 50 条
  • [41] HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples
    Kahle, Erin
    Campbell, Mary
    Lingappa, Jairam
    Donnell, Deborah
    Celum, Connie
    Ondondo, Raphael
    Mujugira, Andrew
    Fife, Kenneth
    Mugo, Nelly
    Kapiga, Saidi
    Mullins, James I.
    Baeten, Jared M.
    AIDS, 2014, 28 (02) : 235 - 243
  • [42] HIV: Silencing HIV-1
    Buckland J.
    Nature Reviews Immunology, 2002, 2 (7) : 458 - 458
  • [43] Antibody responses to envelope glycoproteins in HIV-1 infection
    Dennis R Burton
    John R Mascola
    Nature Immunology, 2015, 16 : 571 - 576
  • [44] High level of HIV-1 drug resistance among patients with HIV-1 and HIV-1/2 dual infections in Guinea-Bissau
    Jespersen, Sanne
    Tolstrup, Martin
    Honge, Bo Langhoff
    Medina, Candida
    Te, David da Silva
    Ellermann-Eriksen, Svend
    Ostergaard, Lars
    Wejse, Christian
    Laursen, Alex Lund
    VIROLOGY JOURNAL, 2015, 12
  • [45] Antibody B cell responses in HIV-1 infection
    Mouquet, Hugo
    TRENDS IN IMMUNOLOGY, 2014, 35 (11) : 549 - 561
  • [46] Antibody responses to envelope glycoproteins in HIV-1 infection
    Burton, Dennis R.
    Mascola, John R.
    NATURE IMMUNOLOGY, 2015, 16 (06) : 571 - 576
  • [47] High level of HIV-1 drug resistance among patients with HIV-1 and HIV-1/2 dual infections in Guinea-Bissau
    Sanne Jespersen
    Martin Tolstrup
    Bo Langhoff Hønge
    Candida Medina
    David da Silva Té
    Svend Ellermann-Eriksen
    Lars Østergaard
    Christian Wejse
    Alex Lund Laursen
    Virology Journal, 12
  • [48] NEUROPSYCHOLOGICAL DEFICITS IN HIV-1 SEROPOSITIVE AND SERONEGATIVE INTRAVENOUS-DRUG-USERS
    HESTAD, K
    AUKRUST, P
    ELLERTSEN, B
    KLOVE, H
    WILBERG, K
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1993, 15 (05) : 732 - 742
  • [49] MARKERS FOR DISEASE PROGRESSION IN INTRAVENOUS-DRUG-USERS INFECTED WITH HIV-1
    ZANGERLE, R
    FUCHS, D
    REIBNEGGER, G
    FRITSCH, P
    WACHTER, H
    AIDS, 1991, 5 (08) : 985 - 991
  • [50] Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure
    Umotoy, Jeffrey C.
    de Taeye, Steven W.
    FRONTIERS IN IMMUNOLOGY, 2021, 12